HLYK — HealthLynked Income Statement
0.000.00%
Last trade - 00:00
- $14.28m
- $15.07m
- $5.72m
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4.02 | 6.13 | 6.5 | 5.86 | 5.72 |
Cost of Revenue | |||||
Gross Profit | 2.17 | 3.84 | 3.54 | 2.83 | 3.37 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 8.46 | 11.3 | 16.8 | 14.5 | 10 |
Operating Profit | -4.44 | -5.13 | -10.3 | -8.66 | -4.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.53 | -5.76 | -10.7 | -8.07 | -3.61 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.53 | -5.76 | -10.7 | -8.07 | -3.61 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -5.53 | -5.76 | -10.4 | -8.82 | -1.01 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.53 | -6.2 | -10.8 | -9.17 | -1.01 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.043 | -0.029 | -0.027 | -0.023 | -0.012 |